New updates in Drug Formulation & Bioavailability started in 2013 and is a platform based on the concept of synergies between “science” and “business”. The presented content and topics will focus on advancements in formulations and cutting edge technologies that can allow cheaper, safer and effective drugs.
Pharmaceutical formulation can have a huge impact on the bioavailability of a given drug and is one of the key factors in the successful development of drug delivery systems. However, many of the drugs in the development pipelines often possess poor physico-chemical properties, which make them difficult to formulate using classic approaches and hence require the use of new and enabling formulation approaches.
Meet R&D people, the pharma industry, increase your awareness and gain more knowledge about this exciting topic.
The meeting will include pre-bookable face-to-face-meetings and will be covered by the media.
Date: 30. September 2020
Time: 8:30 – 17:00
The target audience consists of:
- Drug formulation professionals from Big Pharma, CDMO’s, Academia
- Early Phase & virtual biotech and pharma companies
- QA & Reg Aff. Managers
- Procurement Managers
Speakers will come from:
Pharmaceutical companies, Excipient manufacturers, CDMO’s, Academia
Topics will include:
- Formulation development design space
- Improving bioavailability of poorly soluble compounds
- Controlled and modified release technologies
- Out-sourcing and in-licensing
- Exploring different routes of administration in enhancing macromolecule delivery
Exhibition with leading solution providers
The most efficient and cost effective way to identify the latest technologies to support your formulation and delivery requirements. Suppliers will be showcasing products that could significantly increase your efficiency & profitability.
Real life case studies
From experts detailing practical advice and best practice for all formulation and delivery specialists. Presented by subject matter experts, these sessions will provide you with the ideal opportunity not only to learn from a real case, but also, examine and exchange views on key industry challenges in a more informal setting.
|Organized by||Co-organizer||In collaboration with|